NMD Pharma
Novo Seeds portfolio company NMD Pharma reports positive top-line Phase I/IIa data in myasthenia gravis - Startup Weekly
NMD Pharma vinder pris i vækstkonkurrence | EY Danmark
NMD Pharma Receives IND Clearance to Start a Phase II
NMD Pharma Lights Up INCUBA/Skejby - Rare Disease Day 2023
NMD Pharma (Denmark) - Video
NMD Pharma
NMD Pharma
NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma
NMD Pharma begins first clinical trial: "Our entire team can be enormously proud"
NMD Pharma A/S | LinkedIn
NMD Pharma gets FDA orphan drug designation
NMD Pharma raises €35m to expand pipeline - European Pharmaceutical Manufacturer
NMD Pharma - PIR International
NMD Pharma
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
ALS Therapy Developer NMD Pharma Obtains $47 Million in New Financing | Call center, Negotiation skills, Therapy
NMD Pharma - Capnova
NMD Pharma (@NMDPharma) / Twitter
Funding round-up: NMD Pharma, MindFi, Neo Medical, TargED Biopharmaceutical, MediBuddy - LaingBuisson News
NMD pulls in $40M from Jeito-led, Roche-backed syndicate, gaining financial muscle to crack myasthenia gravis market | Fierce Biotech
Jeito Capital Becomes Key Investor in NMD Pharma as Part of a €35 Million New Financing | Business Wire
NMD Pharma A/S | LinkedIn
